Indian leading generic drug manufacturer, Natco pharma submits the generic version of ibrutinib drug approval application to USFDA. The strength would be 140 mg, 280 mg, 420 mg and 560… Continue Reading
Blogs
Hetero Launches Generic Lapatinib ‘Hertab’ a Breast Cancer Treatment Drug in India
11th January 2019, Hyderabad, India: Hetero, one of India’s leading Indian generic pharmaceutical company and the globally biggest manufacturer of anti-retroviral drugs, announce the release of generic version of Lapatinib… Continue Reading
XBIRA Abiraterone Acetate 250 mg (Generic Zytiga) in India: Price and How to Buy
1. What is Abiraterone Acetate and what it is useful for 2. What is Prostate? 3. Prostate Cancer treatment drug 4. XBIRA 250 mg Abiraterone Acetate (Generic Zytiga) in India… Continue Reading
The Medicines Patent Pool signed a license to expand access to hepatitis C treatment, Glecaprevir / Pibrentasvir
On 12 November 2018 – The Medicines Patent Pool (MPP) has announced a new, royalty-free licence agreement with AbbVie for Glecaprevir / Pibrentasvir (G/P). The agreement was launched at the… Continue Reading
Cipla gets Approval for Valcyte Generic Valganciclovir 450 mg Tablets
On 12th November 2018, the United States Food and Drugs Administration (US FDA) has provided the final approval to the Cipla Limited’s Valganciclovir 450mg Tablets, the generic version of Roche… Continue Reading